Marc Pelletier, MD
Thoracic Surgery · New Haven
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 32 years
- Graduated 1994
Offices
1 location · Yale University · 2,632 clinicians in this group
Hospitals listed: 077143 · 077163 · Lawrence & Memorial Hospital · Yale-New Haven Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pelletier’s office at (203) 785-2140 to ask if they take your plan before you enroll.
California Medical Board record
Licence A71958 · Current
Licensed to practise in California · since 2000 · expires 2027-12-31 · Dalhousie University Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Thoracic Surgery - Thoracic and Cardiac Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Lawrence & Memorial HospitalNew London, CTAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Yale New Haven Health System, which runs 7 hospitals in 2 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.189, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.126, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.371, Oct 2024 – Sep 2025
- Yale-New Haven HospitalNew Haven, CTAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Yale New Haven Health System, which runs 7 hospitals in 2 statesHome of Yale Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.7 (0.53 to 0.87), Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 137.48 (105.24 to 169.71) · 374 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative hemorrhage or hematoma rate: 1.18 (0.15 to 2.22) · 4,745 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 4.13 (0.85 to 7.4) · 2,077 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 3.12 (1.01 to 5.23) · 2,251 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.574, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.371, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.584, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.7 (3.1 to 4.6) · 1,744 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 1,640 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Lawrence & Memorial Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.189 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.126 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.371 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 865 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.69 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.99 (112.85 to 223.14) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 162 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 456 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 586 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.4 · 265 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,205 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,519 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.38 (0.18 to 0.57) · 5,615 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.7 (1.44 to 5.97) · 774 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.66 to 3.86) · 738 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.26 (1.91 to 18.61) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.07 (2.06 to 10.08) · 189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.33) · 4,944 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 26 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.288 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 716 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 38.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 30.5 · 486 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.5 · 597 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (4.8 to 9.2) · 216 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 216 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 229 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.5 to 18.4) · 292 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.1) · 371 cases | No different | Jan 2024 – Dec 2024 |
What patients said (919 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Yale-New Haven Hospital
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.7 (0.53 to 0.87) | Better | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.48 (105.24 to 169.71) · 374 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.18 (0.15 to 2.22) · 4,745 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.13 (0.85 to 7.4) · 2,077 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.12 (1.01 to 5.23) · 2,251 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.371 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.584 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.7 (3.1 to 4.6) · 1,744 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,640 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.6 (0 to 1.32) · 3,885 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 133 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 221 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.4 · 352 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.1 · 1,097 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 1,527 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 985 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.2 · 11,810 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.28) · 20,172 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.13 to 0.43) · 21,425 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.82 (1.5 to 4.14) · 5,246 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0.31 to 2.45) · 2,232 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.47 (0.19 to 2.74) · 1,122 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.65 (0.31 to 0.98) · 19,374 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 261 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.455 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.907 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 705 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 2,419 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.4 · 463 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 1,281 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.5 · 1,650 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 2,832 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (10 to 12.7) · 1,744 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 260 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.6 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 22.3 · 665 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (10.3 to 17.2) · 1,259 cases | No different | Jan 2022 – Dec 2024 |
What patients said (863 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$111,263
Medicare paid this office $111,263 for 141 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Coronary artery bypass using artery graft, 1 graft | 18 | $21,128 | $1,174 |
| Replacement of aortic valve through the skin and femoral artery | 33 | $18,742 | $568 |
| New patient visit (60+ min) | 68 | $8,960 | $132 |
| Long return visit (40+ min) | 11 | $1,088 | $99 |
| Exclusion of appendage of left upper chamber of heart performed during other procedure on chest | 11 | $1,072 | $97 |
See all 7 services
| Coronary artery bypass using artery graft, 1 graft | 18 | $21,128 | $1,174 |
| Replacement of aortic valve through the skin and femoral artery | 33 | $18,742 | $568 |
| New patient visit (60+ min) | 68 | $8,960 | $132 |
| Long return visit (40+ min) | 11 | $1,088 | $99 |
| Exclusion of appendage of left upper chamber of heart performed during other procedure on chest | 11 | $1,072 | $97 |
| Short return visit (20+ min) | 12 | $648 | $50 |
| Harvest of vein using an endoscope | 18 | $217 | $12 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 14 | More than 52% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Replacement of aortic valve through the skin and femoral artery | 72 | 52 | 51 | 37 | 34 | 33 |
| Coronary artery bypass using artery graft, 1 graft | 27 | 24 | 24 | 30 | 20 | 18 |
| Harvest of vein using an endoscope | 33 | 25 | – | 16 | 24 | 18 |
| Replacement of aortic valve on heart-lung machine | 11 | – | 11 | 15 | – | – |
| Coronary artery bypass using vein or artery graft, 2 grafts | 12 | – | – | – | – | – |
| Exclusion of appendage of left upper chamber of heart performed during other procedure on chest | – | – | – | – | – | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
141 Original Medicare patients in 2024. Average age 76 · Women 42% · Also on Medicaid 8% · Health risk score 1.57. At or below the middle of the specialty; the typical cardiac surgery clinician is at 1.73.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 55% · Atrial fibrillation 50% · Chronic kidney disease 43% · Diabetes 40% · COPD 27% · Depression 26% · Cancer 17% · Stroke 16% · Dementia 9%.
The office billed $663,814, Medicare allowed $140,123 and paid $111,263; for 250 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 141 | 250 | 76 | 1.57 | $663,814 | $111,263 |
| 2023 | 131 | 262 | 76 | 1.54 | $667,330 | $113,719 |
| 2022 | 137 | 296 | 78 | 1.53 | $872,579 | $141,515 |
| 2021 | 165 | 302 | 77 | 1.57 | $1,059,258 | $167,976 |
| 2020 | 142 | 272 | 76 | 1.94 | $824,640 | $132,983 |
| 2019 | 237 | 436 | 76 | 2.11 | $1,405,543 | $252,838 |
| 2018 | 280 | 585 | 77 | 1.93 | $1,963,742 | $340,835 |
| 2017 | 303 | 628 | 77 | 1.94 | $1,772,977 | $304,971 |
| 2016 | 193 | 369 | 76 | 2.02 | $1,214,598 | $201,700 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Coronary artery bypass using artery graft, 1 graft | 20 | $23,052 | $1,153 |
| Replacement of aortic valve through the skin and femoral artery | 34 | $19,732 | $580 |
| New patient visit (60+ min) | 75 | $10,349 | $138 |
| Long return visit (40+ min) | 13 | $1,318 | $94 |
| Harvest of vein using an endoscope | 24 | $298 | $12 |
2022: 6 services
| Coronary artery bypass using artery graft, 1 graft | 30 | $32,509 | $1,084 |
| Replacement of aortic valve on heart-lung machine | 15 | $22,280 | $1,485 |
| Replacement of aortic valve through the skin and femoral artery | 37 | $21,829 | $590 |
| New patient visit (60+ min) | 85 | $12,207 | $144 |
| Long return visit (40+ min) | 12 | $1,365 | $114 |
| Harvest of vein using an endoscope | 16 | $209 | $13 |
2021: 5 services
| Replacement of aortic valve through the skin and femoral artery | 51 | $30,957 | $607 |
| Coronary artery bypass using artery graft, 1 graft | 24 | $27,477 | $1,145 |
| Replacement of aortic valve on heart-lung machine | 11 | $15,280 | $1,389 |
| New patient visit (60+ min) | 90 | $13,035 | $145 |
| Long return visit (40+ min) | 12 | $1,507 | $116 |
2020: 6 services
| Coronary artery bypass using artery graft, 1 graft | 24 | $33,706 | $1,404 |
| Replacement of aortic valve through the skin and femoral artery | 52 | $32,471 | $624 |
| New patient visit (60+ min) | 62 | $8,327 | $134 |
| Long return visit (40+ min) | 11 | $972 | $88 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $556 | $51 |
| Harvest of vein using an endoscope | 25 | $340 | $14 |
2019: 8 services
| Replacement of aortic valve through the skin and femoral artery | 72 | $52,934 | $735 |
| Coronary artery bypass using artery graft, 1 graft | 27 | $41,321 | $1,530 |
| Replacement of aortic valve on heart-lung machine | 11 | $18,066 | $1,642 |
| New patient visit (45+ min) | 87 | $12,206 | $140 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $5,220 | $119 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 12 | $4,289 | $357 |
| Long return visit (40+ min) | 23 | $2,889 | $126 |
| Harvest of vein using an endoscope | 33 | $461 | $14 |
2018: 11 services
| Coronary artery bypass using artery graft, 1 graft | 49 | $66,953 | $1,366 |
| Replacement of aortic valve through the skin and femoral artery | 70 | $51,957 | $742 |
| Replacement of aortic valve on heart-lung machine | 23 | $38,660 | $1,681 |
| Replacement of mitral valve on heart-lung machine | 14 | $31,776 | $2,270 |
| New patient visit (45+ min) | 136 | $18,988 | $140 |
| Coronary artery bypass using vein or artery graft, 3 grafts | 15 | $7,106 | $474 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 19 | $6,809 | $358 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,688 | $117 |
| Long return visit (40+ min) | 52 | $6,489 | $125 |
| Coronary artery bypass using vein or artery graft, 1 graft | 11 | $1,794 | $163 |
| Harvest of vein using an endoscope | 50 | $707 | $14 |
2017: 11 services
| Coronary artery bypass using artery graft, 1 graft | 41 | $51,926 | $1,266 |
| Replacement of aortic valve through the skin and femoral artery | 71 | $51,385 | $714 |
| Replacement of aortic valve on heart-lung machine | 28 | $48,646 | $1,737 |
| Replacement of mitral valve on heart-lung machine | 14 | $32,912 | $2,351 |
| New patient visit (45+ min) | 120 | $15,968 | $133 |
| Long return visit (40+ min) | 72 | $9,103 | $123 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 25 | $8,628 | $345 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $8,178 | $112 |
| Return visit (30+ min) | 17 | $1,392 | $82 |
| Harvest of vein using an endoscope | 42 | $558 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $370 | $15 |
2016: 8 services
| Coronary artery bypass using artery graft, 1 graft | 30 | $41,398 | $1,380 |
| Replacement of aortic valve through the skin and femoral artery | 50 | $34,163 | $683 |
| Replacement of aortic valve on heart-lung machine | 11 | $15,664 | $1,424 |
| New patient visit (45+ min) | 69 | $9,397 | $136 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 12 | $3,980 | $332 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,218 | $111 |
| Long return visit (40+ min) | 25 | $3,170 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $293 | $15 |
Drugs they prescribed that Part D paid
$4,239
Pharmacies billed $4,239 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
107 generic and fewer than 11 brand-name prescriptions · $4,239 in drug cost · 18 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Furosemide | 13 | $20 | $1 |
Year by year
| 2024 | 115 | 52 | None | None | $4,239 |
| 2023 | 78 | 38 | None | None | $3,152 |
| 2022 | 68 | 37 | None | None | $586 |
| 2021 | 45 | 27 | None | None | $1,852 |
| 2020 | 36 | 15 | None | None | $2,571 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Metoprolol | 12 | $84 | $7 |
Money from drug and device companies
$6,491 in 2025
| 2025 | 13 | 33 | $3,548 | $6,491 |
| 2024 | 17 | 127 | $31,270 | $56,652 |
| 2023 | 21 | 91 | $12,340 | $21,113 |
| 2022 | 15 | 95 | $21,500 | $29,455 |
| 2021 | 10 | 36 | $1,125 | $3,528 |
| 2020 | 5 | 32 | $7,313 | $10,041 |
| 2019 | 9 | 63 | $13,825 | $23,303 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ethicon US | Surgicel Nu-Knit | $2,748 | 1 payment
|
| Medtronic | Avalus | $2,121 | 13 payments
|
| Edwards Lifesciences | None | $516 | 5 payments
|
| Abbott Laboratories | Epic | $435 | 5 payments
|
| Pulse Biosciences | Cellfx | $168 | 1 payment
|
| Bolton Medical | Thoraflex Hybrid | $139 | 1 payment
|
See all 33 published payments
| Edwards Lifesciences | Meals · 2025-11-07 | None | $80 |
| EnableCV | Meals · 2025-10-08 | Thruport Systems Intraclude Intra-Aortic Occlusion Device | $99 |
| Medtronic | Meals · 2025-09-18 | Corevalve Evolut R | $135 |
| Abbott Laboratories | Meals · 2025-08-14 | Epic | $83 |
| Medtronic | Paid to speak or teach · 2025-08-13 | Avalus | $800 |
| Abbott Laboratories | Meals · 2025-08-12 | Epic | $175 |
| Medtronic | Meals · 2025-07-18 | Avalus | $165 |
| Bolton Medical | Meals · 2025-07-18 | Thoraflex Hybrid | $139 |
| Abbott Laboratories | Meals · 2025-06-19 | Epic | $91 |
| Medtronic | Travel · 2025-06-10 | Penditure | $268 |
| Medtronic | Travel · 2025-06-10 | Penditure | $73 |
| Medtronic | Meals · 2025-05-12 | Avalus | $46 |
| Medtronic | Meals · 2025-05-12 | Na | $115 |
| Nexus Medical Technologies | Meals · 2025-05-04 | None | $33 |
| Edwards Lifesciences | Meals · 2025-05-03 | None | $52 |
| Pulse Biosciences | Meals · 2025-05-03 | Cellfx | $168 |
| Edwards Lifesciences | Meals · 2025-05-02 | None | $215 |
| Supreme Orthopedic Systems | Meals · 2025-05-02 | None | $42 |
| Medtronic | Meals · 2025-04-30 | None | $75 |
| AtriCure | Meals · 2025-04-24 | Synergy Ablation System | $124 |
| Edwards Lifesciences | Meals · 2025-04-10 | None | $148 |
| Medtronic | Meals · 2025-04-03 | Avalus | $109 |
| Stryker | Meals · 2025-02-27 | Na | $23 |
| Medtronic | Meals · 2025-02-25 | Corevalve Evolut R | $27 |
| Medtronic | Meals · 2025-02-25 | Avalus | $146 |
| Abiomed | Meals · 2025-02-20 | None | $27 |
| Edwards Lifesciences | Meals · 2025-02-18 | None | $21 |
| Ethicon US | Consulting · 2025-02-06 | Surgicel Nu-Knit | $2,748 |
| Abbott Laboratories | Meals · 2025-02-04 | Epic | $81 |
| Argentum Medical | Entertainment · 2025-01-28 | None | $14 |
| Medtronic | Meals · 2025-01-25 | Avalus | $131 |
| Medtronic | Meals · 2025-01-25 | Penditure | $33 |
| Abbott Laboratories | Meals · 2025-01-09 | Epic | $5 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $56,652
| Medtronic | Avalus | $33,948 | 51 payments
|
| Edwards Lifesciences | Mitris Resilia Mitral Valve | $15,159 | 30 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $5,446 | 17 payments
|
| Abbott Laboratories | Epic | $693 | 8 payments
|
| Bolton Medical | Treo Abdominal Stent-Graft System | $331 | 2 payments
|
| Atricure | Atriclip Laa Exclusion System | $220 | 4 payments
|
| EnableCV | Thruport Systems Intraclude Intra-Aortic Occlusion Device | $175 | 2 payments
|
| Ethicon US | Surgicel Nu-Knit | $159 | 2 payments
|
| Zimmer Biomet Holdings | Sternalock Blu System | $146 | 1 payment
|
| Stryker | Na | $106 | 2 payments
|
| DePuy Synthes Sales | Matrixrib | $93 | 2 payments
|
| LeMaitre Vascular | Restoreflow | $67 | 1 payment
|
| Abiomed | Impella | $31 | 1 payment
|
| Solventum | Prevena | $24 | 1 payment
|
| Teleflex | Manta | $21 | 1 payment
|
| Argentum Medical | None | $19 | 1 payment
|
| Baxter Healthcare | Preveleak | $15 | 1 payment
|
2023: $21,113
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $8,431 | 13 payments
|
| Medtronic | Corevalve Evolut R | $6,579 | 28 payments
|
| Edwards Lifesciences | Mitris Resilia Mitral Valve | $3,662 | 18 payments
|
| Abbott Laboratories | Epic | $725 | 8 payments
|
| Saphena Medical | Venapax | $383 | 2 payments
|
| Nuwellis | Aquadex Smartflow Console | $189 | 1 payment
|
| Abiomed | Impella | $170 | 2 payments
|
| Bolton Medical | Treo Abdominal Stent-Graft System | $149 | 1 payment
|
| Cook Medical | Zenith Alpha | $135 | 1 payment
|
| Stryker | Na | $126 | 1 payment
|
| HemoSonics | Quantra Qplus System | $108 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $98 | 1 payment
|
| Corcym | Perceval | $89 | 3 payments
|
| Baxter Healthcare | Coseal | $58 | 3 payments
|
| Rock Medical Orthopedics | None | $52 | 1 payment
|
| Boston Scientific | None | $46 | 1 payment
|
| Lsi Solutions | Cor Knot | $33 | 1 payment
|
| Teleflex | Quikclot | $28 | 1 payment
|
| Artivion | Cryovalve Sg Pulmonary Human Heart Valve | $24 | 1 payment
|
| Getinge USA Sales | Cardiosave Hybrid, Type B Plug | $19 | 1 payment
|
| LeMaitre Vascular | Restoreflow | $10 | 1 payment
|
2022: $29,455
| Medtronic | Avalus | $17,981 | 46 payments
|
| AtriCure | Synergy Ablation System | $9,779 | 18 payments
|
| Abbott Laboratories | Portico | $844 | 11 payments
|
| Corcym | Perceval | $134 | 4 payments
|
| W. L. Gore & Associates | C3 Delivery System | $134 | 1 payment
|
| Quest Medical | Mps2 Console | $127 | 1 payment
|
| Stryker | Na | $109 | 1 payment
|
| Artivion | Cryovalve Sg Pulmonary Human Heart Valve | $95 | 2 payments
|
| Boston Scientific | General - Structural Heart | $64 | 2 payments
|
| LeMaitre Vascular | Restoreflow | $48 | 2 payments
|
| Edwards Lifesciences | Mitris Resilia Mitral Valve | $44 | 2 payments
|
| Baxter Healthcare | Coseal | $42 | 2 payments
|
| Ethicon US | Dermabond Prineo | $19 | 1 payment
|
| KLS-Martin L.P. | None | $19 | 1 payment
|
| Abiomed | Impella | $16 | 1 payment
|
2021: $3,528
| Medtronic | Avalus | $1,608 | 19 payments
|
| Artivion | Cardiac Non-Synergraft | $511 | 3 payments
|
| Abbott Laboratories | Mitraclip System | $353 | 5 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $334 | 2 payments
|
| Boston Scientific | General Pain Management | $164 | 2 payments
|
| Bolton Medical | Relay Grafts | $147 | 1 payment
|
| Nuwellis | Aquadex Smartflow Console | $137 | 1 payment
|
| Cook | Lunderquist | $125 | 1 payment
|
| LivaNova USA | Perceval | $119 | 1 payment
|
| Aziyo Biologics | Ecm Patch,Pouch | $30 | 1 payment
|
2020: $10,041
| Medtronic Vascular | Avalus | $8,848 | 21 payments
|
| Abbott Laboratories | Trifecta Gt Tissue Heart Valve | $858 | 6 payments
|
| Atricure | Atricure Synergy Ablation System | $268 | 2 payments
|
| Abiomed | Impella | $54 | 2 payments
|
| Baxter Healthcare | Floseal | $13 | 1 payment
|
2019: $23,303
| Medtronic Vascular | Avalus | $16,234 | 35 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $5,231 | 18 payments
|
| Acutus Medical | None | $1,422 | 1 payment
|
| Abbott Laboratories | Cardiovascular- Research Only | $220 | 2 payments
|
| Quest Medical | None | $81 | 1 payment
|
| AtriCure | Atricure Atriclip Laa Exclusion | $50 | 2 payments
|
| LivaNova USA | Xtra Autotransfusion System | $28 | 1 payment
|
| Lsi Solutions | Cor Knot | $23 | 1 payment
|
| Baxter Healthcare | Floseal | $13 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ATRICURE, INC. · Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial · 2024 | Their institution | $265,530 |
| ATRICURE, INC. · Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial · 2023 | Their institution | $71,075 |
| Abbott Laboratories · Portico Ng Approval Study · 2022 | Their institution | $56,527 |
| ATRICURE, INC. · A Multicenter Patient Registry for Outcomes From Comprehensive Ablation Treatments of Atrial Arrhythmias · 2024 | Their institution | $45,500 |
| Abbott Laboratories · Portico Ng Approval Study · 2023 | Their institution | $26,894 |
| CryoLife, Inc. · Clinical Trial of the on-X Valve Using Low Dose Anticoagulation · 2020 | Their institution | $18,450 |
| Amgen Inc. · A Randomized Trial of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery (Newton-Cabg) · 2021 | Their institution | $15,943 |
| Abbott Laboratories · Portico Ng Approval Study · 2021 | Their institution | $14,250 |
| Abbott Laboratories · Evaluation of the Portico Ng (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis · 2024 | Their institution | $9,533 |
| CryoLife, Inc. · Clinical Trial of the on-X Valve Using Low Dose Anticoagulation · 2019 | Their institution | $8,975 |
| Amgen Inc. · A Randomized Trial of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery (Newton-Cabg) · 2023 | Their institution | $8,971 |
| Amgen Inc. · A Randomized Trial of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery (Newton-Cabg) · 2022 | Their institution | $6,888 |
| Abbott Laboratories · Portico Ng Approval Study · 2024 | Their institution | $4,695 |
| Abbott Laboratories · Nct04011722--Portico Next Generation Approval Study · 2025 | Their institution | $4,407 |
| Abbott Laboratories · Evaluation of Theporticong(Next Generation)Transcatheteraorticvalvein High and Extreme Risk Patients With Symptomatic Severeaorticstenosis · 2024 | Their institution | $500 |
Professional record
- NPI
- 1699883207
- Licence
- CA A71958California A71958: Current · expires 2027-12-31
- Group
- Yale University
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Thoracic surgery (208G00000X)
- Mailing address
- 330 Cedar St Bldg Suite204, New Haven, CT, 06510
- NPI first listed
- 2006-08-25
- NPI last updated
- 2025-02-24
- NPI record certified
- 2025-02-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 11100 Euclid Ave, Cleveland, OH, 44106 · 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.